August 24, 2017 Environ, Ag./Food & Bev Lab Top-10 Life Science Tools M&A, Partnerships

Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company has certain exclusive rights to provide Illumina’s forensic sequencing technology to forensic customers, including for criminal casework and other human and nonhuman forensic applications.... Read more

August 18, 2017 Lab Top-10 M&A, Partnerships

Helix Teams Up with Illumina Accelerator to Drive Innovation and DNA-Powered Products for Consumers

Calling innovative startups building consumer applications to deliver DNA insights powered by Helix’s Exome+ and next generation sequencing August 17, 2017 05:00 AM Pacific Daylight Time SAN CARLOS, Calif.–(BUSINESS WIRE)–Helix, a personal genomics company, today announced a collaboration with Illumina Accelerator, the world’s first business accelerator focused solely on creating an innovation ecosystem for the... Read more

June 29, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more

June 26, 2017 Informatics & Software Lab Top-10 Life Science Tools M&A, Partnerships

Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project. In a little over a year since Illumina announced the Bioinformatics and Clinical Interpretation Partnership with Genomics England, the partnership has now set... Read more

June 1, 2017 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Philips and Illumina team up with Navican, an Intermountain Healthcare Company, to Accelerate the Delivery of Precision Medicine to Health Systems Worldwide

– New “turnkey” approach to precision medicine seeks to deliver Intermountain’s best practices into a streamlined service to be integrated at the point of care – Solution’s goal is to benefit late stage cancer patients through advanced analytics and expert decision support, combined with providing better access to targeted treatments and clinical trials NEWS PROVIDED... Read more

May 30, 2017 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Illumina to Webcast Live Presentation at the Goldman Sachs Global Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 13, 2017. The live webcast is scheduled to begin at 2:40 PM PT and will feature a brief overview of the company by Francis deSouza, President and CEO, followed by a... Read more

May 22, 2017 Lab Top-10 Life Science Tools PR/Corporate

Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer. Van Oene was previously Illumina’s Senior Vice President of the Americas region and subsequently named interim Chief Commercial Officer in late 2016. “Mark is a great leader for our commercial organization, possessing deep genomics expertise and over a... Read more

May 4, 2017 Lab Top-10 PR/Corporate

Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 18, 2017. The live webcast is scheduled to begin at 10:40 AM PT and will feature a brief overview of the company by Marc Stapley, Executive Vice President... Read more

April 13, 2017 Lab Top-10 Life Science Tools Liq. Handling & Robotics M&A, Partnerships

Hamilton Robotics Collaborates with Illumina in the European Union for Streamlined Noninvasive Prenatal Testing Solution

Automated Whole-Genome Sequencing Approach Provides Confidence in Results with Increased Sample Throughput and Decreased Turnaround Time Reno, Nev. (April13, 2017) – Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (NGS) workflow is a... Read more